Healthy Lifestyle Intervention on Diabetes Risk Reduction Among Bruneian Young Adults

January 2, 2020 updated by: Alifah Nur'ain Haji Mat Rasil, Universiti Brunei Darussalam

Effectiveness of Healthy Lifestyle Intervention on Diabetes Risk Reduction Among Bruneian Young Adults: a Randomised Controlled Trial

The general research question posed was 'How effective is a healthy lifestyle intervention using behavioural change strategies in the prevention of Type 2 Diabetes Mellitus (T2DM)?'.

The main aim was to assess the effectiveness of a healthy lifestyle intervention implemented for 12 weeks via face-to-face group sessions and by using social media tools (Facebook and WhatsApp) for young adults at risk of T2DM.

The hypothesis was that this healthy lifestyle intervention may be effective in terms of initiating an increased physical activity (PA) level and a healthy balanced dietary intake resulting in improvements of other T2DM risk factors at 12 weeks.

Study Overview

Detailed Description

The specific research question posed was 'Is a healthy lifestyle intervention using Social Cognitive Theory (SCT)-based PA and dietary strategies implemented for 12 weeks through face-to-face group sessions and social media tools effective in the initiation and maintenance of increased PA level and healthy balanced dietary intake, resulting in improvements of T2DM risk score, anthropometrics, metabolic parameters and SCT-related psychosocial factors among Bruneian young adults at risk of T2DM?'.

Study design was two-arm parallel, stratified with simple randomisation, and assessor-blinded randomised controlled trial. Participants were randomly allocated into intervention group and control group. Participants were students and alumni of Universiti Brunei Darussalam and Universiti Teknologi Brunei who were overweight-obese at risk of T2DM with a mean age of 23.1 (2.48) years old. Intervention group went through a healthy lifestyle intervention using evidence-based SCT strategies emphasising on PA and diet for 12 weeks, while the control group only received leaflets on healthy lifestyle with no further guidance. Outcomes measured were changes from baseline at week 0 to post-intervention at week 13 between intervention and control groups. Outcomes were changes in diabetes risk score, anthropometrics, metabolic parameters, PA, dietary intake and SCT-related psychosocial factors, with repeated-measures ANOVA as the main analysis.

Study Type

Interventional

Enrollment (Actual)

71

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Bandar Seri Begawan
      • Brunei, Bandar Seri Begawan, Brunei Darussalam, BE1410
        • PAPRSB Institute of Health Sciences, Universiti Brunei Darussalam

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 29 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Bruneian including permanent residents
  • BMI from 25.00 to 39.99 kg/m2
  • American Diabetes Association (ADA) diabetes risk score of at least 3 and maximum score of 8
  • Mentally and physically fit with no chronic conditions
  • Without medical conditions that could influence glucose metabolism and insulin resistance
  • Answered 'No' to all 6 questions in questionnaire-based pre-exercise risk assessment
  • Not actively participating in other healthy lifestyle programmes
  • Had access to computer or mobile phone with Internet

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
Intervention group went through a healthy lifestyle intervention using evidence-based SCT strategies emphasising on PA and diet for 12 weeks via face-to-face sessions and social media tools (Facebook and WhatsApp)

The main goal was to provide knowledge and skills for targeted population in order for them to adapt healthy lifestyle throughout their life. At the end of intervention, participants were expected to be fully equipped with necessary knowledge and fundamental skills in adapting and maintaining healthy lifestyle throughout their life. Gradual improvements were emphasised and at least 5% loss of initial body weight was expected, aiming for at least 0.5% loss in the first month.

It was divided into three phases (preparation, implementation, maintenance) focusing on PA and diet, in which self-efficacy enhancement and self-regulatory skills were emphasised during the first month of intervention.

Other Names:
  • Be Healthy Camp
No Intervention: Control group
Control group only received leaflets on healthy lifestyle with no further guidance.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in diabetes risk score from week 0 to week 13
Time Frame: 12 weeks
Using Finnish Diabetes Risk Score (FINDRISC) questionnaire, with minimum score of 0 and maximum score of 22. Score less than 7 as low risk, 7 to 11 as slightly elevated, 12 to 14 as moderate risk, 15 to 20 as high risk and more than 20 as very high risk.
12 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in weight (kg)
Time Frame: 12 weeks
Using digital weighing scale
12 weeks
Change in weight (%)
Time Frame: 12 weeks
Using digital weighing scale
12 weeks
Height in cm
Time Frame: At baseline
Using digital weighing scale
At baseline
Change in body mass index (BMI) (kg/m2)
Time Frame: 12 weeks
Calculated with weight and height
12 weeks
Change in waist circumference (WC) (cm)
Time Frame: 12 weeks
Measured at the midpoint between the lower border of the ribcage and iliac crest with tape measure
12 weeks
Change in hip circumference (HC) (cm)
Time Frame: 12 weeks
Measured at the largest portion of the buttocks with tape measure
12 weeks
Change in waist-to-hip ratio (WHR)
Time Frame: 12 weeks
Calculated with WC and HC
12 weeks
Change in fasting blood glucose (FBG) (mmol/l)
Time Frame: 12 weeks
With finger-pricking and AccuTrend Plus System blood analyses
12 weeks
Change in fasting blood total cholesterol (TC) (mmol/l)
Time Frame: 12 weeks
With finger-pricking and AccuTrend Plus System blood analyses
12 weeks
Change in fasting blood triglycerides (TG) (mmol/l)
Time Frame: 12 weeks
With finger-pricking and AccuTrend Plus System blood analyses
12 weeks
Change in systolic blood pressure (SBP) (mmHg)
Time Frame: 12 weeks
Using OMRON automated blood pressure monitor
12 weeks
Change in diastolic blood pressure (DBP) (mmHg)
Time Frame: 12 weeks
Using OMRON automated blood pressure monitor
12 weeks
Change in resting heart rate (pulse/min)
Time Frame: 12 weeks
Using OMRON automated blood pressure monitor
12 weeks
Change in vigorous PA metabolic task (MET) (min/week)
Time Frame: 12 weeks
Using short-form international PA questionnaire (SF-IPAQ)
12 weeks
Change in moderate PA MET (min/week)
Time Frame: 12 weeks
Using SF-IPAQ
12 weeks
Change in walking MET (min/week)
Time Frame: 12 weeks
Using SF-IPAQ
12 weeks
Change in total PA MET (min/week)
Time Frame: 12 weeks
Using SF-IPAQ
12 weeks
Change in sitting time (hrs/day)
Time Frame: 12 weeks
Using SF-IPAQ
12 weeks
Change in intake of carbohydrates (servings/day)
Time Frame: 12 weeks
Using 4-day dietary record
12 weeks
Change in intake of protein (servings/day)
Time Frame: 12 weeks
Using 4-day dietary record
12 weeks
Change in intake of fruits (servings/day)
Time Frame: 12 weeks
Using 4-day dietary record
12 weeks
Change in Intake of vegetables (servings/day)
Time Frame: 12 weeks
Using 4-day dietary record
12 weeks
Change in intake of water in (litres/day)
Time Frame: 12 weeks
Using 4-day dietary record
12 weeks
Change in motivation score
Time Frame: 12 weeks
Using University of Rhode Island Change Assessment (URICA) with minimum score of -2 and maximum score of 14. The higher the score, the higher the motivation.
12 weeks
Change in social support (diet) score
Time Frame: 12 weeks
Using social cognitive theory (SCT) constructs scale with minimum score of 1 and maximum score of 4. Higher scores indicate better support for eating healthy.
12 weeks
Change in social support (PA) score
Time Frame: 12 weeks
Using social cognitive theory (SCT) constructs scale with minimum score of 1 and maximum score of 4. Higher scores indicate better support for exercising
12 weeks
Change in overcoming barriers (PA) score
Time Frame: 12 weeks
Using social cognitive theory (SCT) constructs scale with minimum score of 1 and maximum score of 4. Higher scores indicate more capabilities to overcome barriers towards exercising
12 weeks
Change in moral disengagement (diet) score
Time Frame: 12 weeks
Using social cognitive theory (SCT) constructs scale with minimum score of 1 and maximum score of 4. Higher scores indicate lack of control in eating
12 weeks
Change in outcome expectations (diet) score
Time Frame: 12 weeks
Using social cognitive theory (SCT) constructs scale with minimum score of 1 and maximum score of 4. Higher scores indicate more positive expectations for dieting
12 weeks
Change in outcome expectations (PA) score
Time Frame: 12 weeks
Using social cognitive theory (SCT) constructs scale with minimum score of 1 and maximum score of 4. Higher scores indicate more positive expectations for exercising
12 weeks
Change in emotional coping (PA) score
Time Frame: 12 weeks
Using social cognitive theory (SCT) constructs scale with minimum score of 1 and maximum score of 4. Higher scores indicate better emotional coping by exercising
12 weeks
Change in self-efficacy (PA) score
Time Frame: 12 weeks
Using social cognitive theory (SCT) constructs scale with minimum score of 1 and maximum score of 4. Higher scores indicate better confidence in exercising
12 weeks
Facilitation (PA) score
Time Frame: 12 weeks
Using social cognitive theory (SCT) constructs scale with minimum score of 1 and maximum score of 4. Higher scores indicate better access to facilities and equipment for exercising
12 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Alifah Nur'ain Haji Mat Rasil, University Brunei Darussalam

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2017

Primary Completion (Actual)

February 27, 2018

Study Completion (Actual)

February 27, 2018

Study Registration Dates

First Submitted

December 27, 2019

First Submitted That Met QC Criteria

January 2, 2020

First Posted (Actual)

January 3, 2020

Study Record Updates

Last Update Posted (Actual)

January 3, 2020

Last Update Submitted That Met QC Criteria

January 2, 2020

Last Verified

January 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All collected data was available only within the research team which consisted of supervisors only:

  • Dr Nik Tuah (main supervisor)
  • Dr Mas Rina Wati Hamid (co-supervisor)
  • Assoc Prof Dr Ayub Sadiq (co-supervisor)

IPD Sharing Time Frame

Throughout Ph.D. course completion until research publications

IPD Sharing Access Criteria

Research team

  • Dr Alifah Nur'ain Haji Mat Rasil (principal investigator)
  • Dr Nik Tuah (main supervisor)
  • Dr Mas Rina Wati Hamid (co-supervisor)
  • Assoc Prof Dr Ayub Sadiq (co-supervisor)

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • ANALYTIC_CODE
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Diabetes Mellitus, Type 2

Clinical Trials on Healthy lifestyle intervention

Subscribe